Clinical Trial Update: A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating whether Dimebon affects the pharmacokinetics of Dextromethorphan; the study in Huntington disease and Alzheimer disease has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Huntington Disease

Drugs mentioned

• Dextromethorphan (dextromethorphan)
• Dimebon (latrepirdine)

Snippet

Sponsor: Pfizer | Conditions: Huntington Disease, Alzheimer Disease | Phase 1 | Status: COMPLETED